Company profile: scPharmaceuticals
1.1 - Company Overview
Company description
- Provider of biopharmaceutical products for subcutaneous delivery, including FUROSCIX, a furosemide injection for subcutaneous use to treat congestion due to fluid overload in adult patients with heart failure, and an investigational subcutaneous ceftriaxone delivery system for outpatient antibiotic therapy. Offers clinical trials, supports investigator-sponsored studies, educational grants, and medical information services.
Products and services
- Clinical Trials: scPharmaceuticals conducts protocol-driven studies evaluating the safety and efficacy of new therapies for subcutaneous delivery
- FUROSCIX: A subcutaneous-formulated furosemide injection engineered to treat congestion from fluid overload in adult patients with heart failure, delivering diuretic therapy via subcutaneous use
- Subcutaneous ceftriaxone delivery system: An investigational system enabling outpatient subcutaneous ceftriaxone antibiotic therapy, aiming to eliminate the need for long-term intravenous catheters.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to scPharmaceuticals
Nurse Assist
HQ: United States
Website
- Description: Provider of medical devices and USP sterile solutions, including prefilled saline syringes for IV flushing, sterile water and normal saline for irrigation and respiratory care, and sterile saline wound flush for moistening, debriding, and cleaning wounds, helping reduce contamination, medication errors, and needlestick injuries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nurse Assist company profile →
Cure Pharmaceutical
HQ: United States
Website
- Description: Provider of specialty pharmaceutical and bioscience drug formulation and delivery technologies, featuring the CUREfilm thin-film platform for sublingual and buccal delivery. Offerings include CUREfilm Blue (sildenafil for ED), oral thin-film insulin, CU-2025g for weight management, an oral Hepatitis B vaccine, and CUREfilm-based nutraceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cure Pharmaceutical company profile →
Vivani Medical
HQ: United States
Website
- Description: Provider of implantable visual prosthetics for blind individuals and developer of NanoPortal technology for miniature, subdermal drug implants delivering steady medication, including NPM-115 for chronic weight management and NPM-119 (under development) for type 2 diabetes; via subsidiary Cortigent, develops targeted neurostimulation for artificial vision and muscle movement restoration in stroke rehabilitation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vivani Medical company profile →
Acorda Therapeutics
HQ: United States
Website
- Description: Provider of commercial-stage biopharmaceutical therapies, identifying, developing and commercializing therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other nervous system disorders. Products include INBRIJA (levodopa inhalation powder for Parkinson’s symptoms), AMPYRA (dalfampridine to improve walking in adults with MS), and the ARCUS drug delivery platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acorda Therapeutics company profile →
Stratagent Life Sciences
HQ: United States
Website
- Description: Provider of specialty drug therapies that are painless and non-invasive for various diseases, developing alternatives to injected treatments based on proprietary microjet technology to deliver large and small therapeutic molecules without a device penetrating into or through the skin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stratagent Life Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for scPharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to scPharmaceuticals
2.2 - Growth funds investing in similar companies to scPharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for scPharmaceuticals
4.2 - Public trading comparable groups for scPharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →